|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/30 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 31/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/4353 | (2013.01) |
| (11) | Number of the document | 3953393 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20730185.4 |
| Date of filing the European patent application | 2020-04-08 | |
| (97) | Date of publication of the European application | 2022-02-16 |
| (45) | Date of publication and mention of the grant of the patent | 2022-12-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2020/060054 |
| Date | 2020-04-08 |
| (87) | Number | WO 2020/208088 |
| Date | 2020-10-15 |
| (30) | Number | Date | Country code |
| 19168253 | 2019-04-09 | EP |
| (72) |
ROVATI, Lucio Claudio , IT
GIORDANI, Antonio , IT
MAGARACI, Filippo , IT
CASELLI, Gianfranco , IT
PIEPOLI, Tiziana , IT
MAGGIONI, Daniele , IT
BONAZZI, Albino , IT
|
| (73) |
Rottapharm Biotech S.r.l. ,
Via Valosa di Sopra 9, 20900 Monza,
IT
|
| (54) | PHARMACEUTICAL COMBINATION OF AN EP4 ANTAGONIST AND IMMUNE CHECKPOINT INHIBITORS FOR THE TREATMENT OF TUMOURS |
| PHARMACEUTICAL COMBINATION OF AN EP4 ANTAGONIST AND IMMUNE CHECKPOINT INHIBITORS FOR THE TREATMENT OF TUMOURS |